Log In
Print
BCIQ
Print
Print this Print this
 

sevuparin (Sevuparin/DF02)

  Manage Alerts
Collapse Summary General Information
Company Dilaforette AB
DescriptionHeparin analog
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentPhase I/II
Standard IndicationMalaria
Indication DetailsTreat malaria
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today